Following last Friday’s decision by the FDA’s vaccine advisory panel to only recommend the use of boosters for patients who are a) immunocompromised, b) overweight or c) both, Bloomberg reports that the FDA has decided to accept the advisory panel’s conclusions, as expected – representing a major victory for “the science” over President Biden’s political priorities.

Continue reading →